Home Newsfeeds HC Wainwright & Co. Downgrades Akerna to Neutral, Lowers Price Target to $0.15

HC Wainwright & Co. Downgrades Akerna to Neutral, Lowers Price Target to $0.15

HC Wainwright & Co. analyst Scott Buck downgrades Akerna (NASDAQ:KERN) from Buy to Neutral and lowers the price target from $1.5 to $0.15.

byBenzinga Newsdesk

August 25, 2022

1 minute read

HC Wainwright & Co. analyst Scott Buck downgrades Akerna (NASDAQ:KERN) from Buy to Neutral and lowers the price target from $1.5 to $0.15.

Dycom Industries Q2 EPS $1.46 Beats $0.99 Estimate, Sales $72.30M Miss $932.74M Estimate

By Bill Haddad

August 24, 6:03 AM

Dycom Industries (NYSE:DY) reported quarterly earnings of $1.46 per share which beat the analyst consensus estimate of $0.99 by 47.47 percent. This is a 143.33 percent increase over earnings of $0.60 per share from the

Baker Hughes Forecasts Dip In FY24 North American Oilfield Spending

By Lekha Gupta

January 25, 8:27 AM

Baker Hughes expects Q1 FY24 revenue of $6.1B-$6.6B and EBITDA of $880M-$960M. In FY24, the company projects revenue of $26.5B-$28.5B and EBITDA of $4.1B-$4.5B, with strong LNG demand and new orders. It expects North American D&C spending to decline and international oilfield spending to grow.

BKR

Aemetis RNG Production Exceeds Plan By 20% During Q2 2023

By Happy Mohamed

June 27, 8:12 AM

Seven dairy digesters, 40-mile biogas pipeline, centralized Biogas-to-RNG facility, and utility pipeline interconnection are operating 24x7 to deliver RNG for the displacement of petroleum-based fuels in trucks, buses,

AMTX

Needham Reiterates Buy on Genpact, Maintains $56 Price Target

By Benzinga Newsdesk

February 10, 6:10 AM

Needham analyst Mayank Tandon reiterates Genpact (NYSE:G) with a Buy and maintains $56 price target.

HC Wainwright & Co. Downgrades Akerna to Neutral, Lowers Price Target to $0.15

Related Posts

Dycom Industries Q2 EPS $1.46 Beats $0.99 Estimate, Sales $72.30M Miss $932.74M Estimate

Baker Hughes Forecasts Dip In FY24 North American Oilfield Spending

Aemetis RNG Production Exceeds Plan By 20% During Q2 2023

Needham Reiterates Buy on Genpact, Maintains $56 Price Target